Content

Inflection Points

Nov 11, 2025

It’s time to reckon with the geopolitics of artificial intelligence

By Frederick Kempe

The world has entered the most consequential tech race since the dawn of the nuclear age, but this time the weapons are algorithms instead of atoms.

Artificial Intelligence
China

EnergySource

Nov 10, 2025

The energy conversation has changed—so must COP30  

By Charles Hendry

At COP30, world leaders have an opportunity to reframe how countries work together to achieve energy security, decarbonization, and affordability.

Americas
Brazil

New Atlanticist

Nov 7, 2025

Hurricane Melissa left $8 billion in damage. Jamaica needs US support to get back on its feet.

By Patricia R. Francis, Maite Gonzalez Latorre

After the devastation caused by Hurricane Melissa, Jamaica needs the United States to invest in the country’s resilience and economic recovery.

Caribbean
Climate Change & Climate Action

Econographics

Nov 7, 2025

Without development finance, the United States can’t deliver on strategic investment

By Jessie Yin

The United States isn't the only traditional lender to move from aid to investment. But the current administration is going to struggle to achieve its strategic goals without effective development finance.

Economy & Business
Inclusive Growth

New Atlanticist

Nov 7, 2025

The Supreme Court might slow Trump’s strategy. But he still has other tariff options.

By Sophia Busch

If the administration’s primary objective is to preserve tariff revenue and counter unfair practices, sections 301, 232, or 122 remain viable alternatives.

Economy & Business
Politics & Diplomacy

New Atlanticist

Nov 7, 2025

Representative Adam Smith on the NDAA, Venezuela, and the United States’ role in the world

By Daniel Hojnacki

The congressman discussed the National Defense Authorization Act and the Trump administration’s attacks on alleged drug-smuggling boats in the Caribbean and Pacific.

Conflict
Defense Industry

Sinographs

Nov 7, 2025

Pharmaceuticals are China’s next trade weapon

By Niels Graham

China supplies most critical drug ingredients to the US, and the dependency is only growing. After the rare earths truce, pharma is an area to watch.

China
Economy & Business

In the News

Nov 7, 2025

Ruggiero in the Washington Post on Trump’s nuclear testing announcement

On November 6, Forward Defense nonresident senior fellow Anthony Ruggiero was quoted in an a Washington Post article entitled “Trump’s ill-defined nuclear test threat compels a response from Putin,” in which he discussed Trump’s motivation to restart nuclear testing.

Arms Control
Nuclear Deterrence

New Atlanticist

Nov 6, 2025

Experts react: Kazakhstan will join the Abraham Accords. Here’s what that means for the US, the Middle East, and Central Asia

By Atlantic Council experts

President Donald Trump announced the news during a White House meeting with Kazakh President Kassym Jomart-Tokayev and other Central Asian leaders. Our experts break down the implications.

Central Asia
Israel

UkraineAlert

Nov 6, 2025

Vladimir Putin’s endless nuclear threats are a sign of Russian weakness

By Stephen Blank

Since 2022, Russian President Vladimir Putin has repeatedly used nuclear threats to deter Western support for Ukraine, but this scare tactic risks exposing Russia's inability to project strength via more conventional means, writes Stephen Blank.

Conflict
Disinformation

Experts

Events